Skip to main content

Table 2 Medications at baseline and six months

From: Placebo-controlled randomized clinical trial of fish oil’s impact on fatigue, quality of life, and disease activity in Systemic Lupus Erythematosus

  Placebo (N=14) Fish oil (N=18)
  Baseline Six months Baseline Six months
Prednisone     
 0 mg/day 5 (36 %) 7 (50 %) 7 (39 %) 5 (28 %)
 ≤7.5 mg/day 5 (36 %) 4 (29 %) 2 (11 %) 1 (6 %)
 >7.5 mg/day 4 (29 %) 3 (21 %) 9 (50 %) 12 (67 %)
 Median [IQR] mg/day 5 [0–20] 3 [0–9] 8 [0–20] 10 [0–15]
Hydroxychloroquine 12 (86 %) 14 (100 %) 16 (89 %) 16 (89 %)
Other Immunosuppressants     
 Cyclophosphamide 0 (0 %) 1 (7 %) 1 (5 %) 1 (5 %)
 Mycophenolate 8 (57 %) 7 (50 %) 7 (39 %) 10 (56 %)
 Azathioprine 2 (14 %) 2 (14 %) 0 (0 %) 0 (0 %)
Misc. Medications     
 Statin 2 (14 %) 2 (14 %) 7 (39 %) 10 (56 %)
 ACE/ARB 9 (64 %) 9 (64 %) 12 (67 %) 14 (78 %)
  1. Background medications for all completers at baseline and study completion. Data presented as number of patients (%) or median and interquartile range [IQR]